radiation and surgery in favor of immunotherapy treatment, according to a new study published in the New England Journal of Medicine. NBC’s Dr. Natalie Azar joins TODAY to break down the findings.

The results of a phase 3 clinical trial published Wednesday in the New England Journal of Medicine showed ... TIL therapy and the other half got an immunotherapy drug called ipilimumab.

A new immunotherapy drug could help some cancer patients avoid surgery. According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine ... latest demonstration of the power of immunotherapy and other new methods doctors ...

More information: Neoadjuvant immunotherapy in locally advanced dMMR colon cancer, New England Journal of Medicine (2024). DOI: 10.1056/NEJMoa2400634 ...

Allow the Sale, Sharing or use of My Personal information for Targeted Advertising If you switch this toggle to “no,” we will not sell or share your personal information with third parties for ...

An international study published in the New England Journal of Medicine provides ... Standard chemotherapy treatments for CLL, plus the immunotherapy treatment rituximab, require patients to ...

In this issue of the Journal, Childs and colleagues present ... 1 This report opens new therapeutic possibilities not only for metastatic renal-cell cancer but also for other solid tumors that ...